Increasing susceptibility of nitric oxide-mediated inhibitory platelet signaling during storage of apheresis-derived platelet concentrates.
Kobsar A, Klinker E, Kuhn S, Koessler A, Yilmaz P, Boeck M, Koessler J
Purpose
The purpose of this paper was to determine the effects of isolating platelets (plt) from whole blood rather than using apheresis platelet concentrates (APC) and storage of APC on nitric-oxide (NO) mediated inhibitory signaling.
Conclusion
Basal vasodilator-stimulated phosphoprotein phosphorylated at Ser239 (VASP Ser 239), cyclic guanosine monophosphate (cGMP), and thrombin receptor activator peptide 6 (TRAP-6) and collagen stimulated plt aggregation were comparable in APC and whole blood plt concentrates (PC) on day 0. However, when 2 nmol/L NO donor diethylamine diazenium diolate (DEA/NO) was added, APC had 2-fold higher VASP Ser 239 and 1.75-fold lower cyclic adenosine monophosphate (cAMP) than PC from whole blood (p<0.05, both). APC that were stored for 2 days at room temperature had 2-fold higher basal VASP Ser 239 and 4-fold higher 2 nmol/L DEA/NO-stimulated VASP Ser 239 than APC stored for 0 days, but cGMP and cAMP levels were unaffected by storage of APCs. Further, in APC stored for 2 days, basal TRAP-6 and collagen-induced Plt aggregation were slightly decreased, and DEA/NO led to a further decrease in TRAP-6 and collagen-induced plt aggregation. After storage of APCs for 5 days at room temperature, basal and 2 nmol/L DEA/NO-stimulated VASP Ser 239 were each 5-fold higher than in APC stored for 0 days, and TRAP-6 and collagen-induced plt aggregation were reduced. Further, on day 5 of APC storage, TRAP-6-induced fibrinogen binding was inhibited by DEA/NO. At all time-points, VASP Ser 239 and cGMP increased in response to 2 or 5 nmol/L DEA/NO, but DEA/NO stimulation had no effect on TRAP-6 or collagen-induced Plt aggregation on day 0 or on TRAP-6-mediated fibrinogen binding on day 0 or 2. As expected, 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one (ODQ) blocked the DEA/NO-stimulated increases in VASP ser 239 phosphorylation, cAMP and cGMP.
Studies (2)
Purpose
The purpose of this study was to determine the effects of storage of APC on VASP phosphorylation, cAMP and cGMP levels, plt aggregation, and fibrinogen binding in the presence or absence of DEA/NO. Apheresis PC were obtained from 7 patients in acid citrate dextrose-A (ACD-A) using a Trima Accel system and were stored for up to 5 days at 22 degrees C on a flatbed shaker.
Summary of Findings
APC that were stored for 2 days at room temperature had higher basal VASP Ser 239 (2 fold, p<0.05) and 2 nmol/L DEA/NO-stimulated VASP Ser 239 (4-fold; p<0.05) than APC stored for 0 days, but cGMP and cAMP levels were unaffected by storage of APC. Further, in APC stored for 2 days, basal TRAP-6 and collagen induced-plt aggregation were slightly decreased, and DEA/NO led to a further decrease in TRAP-6 and collagen-induced plt aggregation. After storage of APC for 5 days at room temperature, basal and 2 nmol/L DEA/NO-stimulated VASP Ser 239 were 5-fold higher than in APCs stored for 0 days (p<0.05, both), and TRAP-6 and collagen-induced plt aggregation was reduced (p<0.05). Further, on day 5 of APC storage, TRAP-6-induced fibrinogen binding was inhibited by DEA/NO. At all time-points, VASP Ser 239 and cGMP increased in response to 2 or 5 nmol/L DEA/NO, but DEA/NO stimulation had no effect on TRAP-6 or collagen-induced plt aggregation on day 0 or on TRAP-6-mediated fibrinogen binding on day 0 or 2. As expected, ODQ blocked DEA/NO-stimulated increases in VASP ser 239 phosphorylation, cAMP and cGMP.
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
NormalPlatforms
ProteinWestern blotCell count/volumeFlow cytometrySmall moleculeImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen components 0 nmol/L DEA/NO2 nmol/L DEA/NO5 nmol/L DEA/NOStorage Storage duration 0 days2 days5 daysFlow cytometry Specific Reaction solution CollagenTRAP-6
Purpose
The purpose of this study was to determine the effects of isolating plt from whole blood rather than using APC on VASP phosphorylation, cAMP and cGMP levels, plt aggregation, and fibrinogen binding in the presence or absence of DEA/NO. PC were prepared by centrifugation of citrated venous blood from 7 healthy patients and used on the day of preparation. APC were obtained from 7 patients in ACD-A using a Trima Accel system and were stored for up to 5 days at 22 degrees C on a flatbed shaker.
Summary of Findings
Basal VASP Ser 239, cGMP, and TRAP-6 and collagen-stimulated plt aggregation were comparable in APC and whole blood PC. However, when 2 nmol/L DEA/NO was added, APC had 2-fold higher VASP Ser 239 and 1.75-fold lower cAMP than whole blood PC (p<0.05, both).
Biospecimens
FluidBloodPreservation Types
None (Fresh)Diagnoses
NormalPlatforms
ProteinWestern blotCell count/volumeFlow cytometrySmall moleculeImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Method of fluid acquisition ApheresisVenipunctureBiospecimen Aliquots and Components Biospecimen components 0 nmol/L DEA/NO2 nmol/L DEA/NO5 nmol/L DEA/NOFlow cytometry Specific Reaction solution CollagenTRAP-6